Former chief of CSIR said – Vaccine will act as a shield against the new variant of Corona

A sigh of relief has come amid the growing threat of Omicron, a new variant of the corona virus in the country. Dr. Rakesh Mishra, former head of the Council of Scientific and Industrial Research Center (CSIR) for Cellular and Molecular Biology, says that the corona vaccine is also effective on the new Omicron variant. He says that the vaccine will act as a shield to protect against corona. Dr. Mishra is also the Director of Tata Institute of Genetics and Society.

Dr. Mishra said that at the beginning of this year, when the country was facing the second wave of corona, the delta variant that came to the fore was extremely dangerous. Now the Omicron from South Africa is more contagious than the delta variant. However, it is a matter of relief that this virus will reach major cities of the country with mild symptoms, which is a very good sign.

He said hybrid immunity against the new variant would be effective. It is being recognized scientifically. I think it has to be protective. Maybe a little less right, but the vaccine can be very helpful in this. Dr. Mishra told that natural immunity is available due to infection. Vaccine immunity comes from the vaccine. At the same time, when a person who has been infected before becomes vaccinated, then hybrid immunity is available. He said that if people have had a natural infection and they have also taken the vaccine together, then this should happen. In big cities, many people have unknowingly infected. That's why a lot of people will have hybrid immunity.